Press

Lawrence O. Gostin

Medicare names first 10 drugs up for price negotiations with the government

Andrew J. Twinamatsiko Lawrence O. Gostin

Drugmakers Tap Big Law Attorneys to Fight Medicare Price Program

Zachary L. Baron

Drugmakers Prep Medicare Pricing Suits for March to High Court

Zachary L. Baron

How the IRA shifted the drug pricing debate

Zachary L. Baron

Pharma’s Challenge to Drug Price Excise Tax Sits on Shaky Ground

Zachary L. Baron

Air Ambulances Lose Medical Surprise Billing Court Challenge

Zachary L. Baron

CMS pauses surprise billing arbitration after court ruling

Zachary L. Baron

US pharmaceutical companies sue to halt cuts in drug prices

Zachary L. Baron

Drugmakers Want to Crush Medicare’s Pricing Power. They’ll Probably Succeed.

Lawrence O. Gostin

Drugmakers Are ‘Throwing the Kitchen Sink’ to Halt Medicare Price Negotiations

S. Sean Tu

After Pushback, J&J Allows Generics of Its TB Drug

Lawrence O. Gostin

HHS Gets Financial Weapon to Crack Down on Contract, Grant Fraud

Zachary L. Baron

Pharma Battling Legal Precedent in Medicare Drug Price Lawsuits

Zachary L. Baron

The Health 202: Big Pharma has a new strategy to fight drug negotiation

Zachary L. Baron

Big Pharma’s legal fight to stop cheaper Medicare drugs, explained

Lawrence O. Gostin

The fight against cancer faces daunting new challenge: debt politics

Drugmakers want to stop Medicare from negotiating prices. Here’s what you should know

Lawrence O. Gostin

Pact allows ACA to require preventive services amid legal battle

S. Sean Tu

WVU research shows how much pharmaceutical companies are capitalizing on rare drug incentives

Zachary L. Baron

Merck fires opening legal salvo in Medicare drug pricing negotiations